Log In Get Started

News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • NeOnc's Phase 2a intranasal NEO100 showed six‑month PFS 48.9% and median OS >26 months, prompting plans to engage FDA.
  • Osisko Gold filed to issue $500M of 2031 senior secured notes to refinance Appian debt and fund Cariboo gold project construction.
  • BlackLine acquired NetNow to integrate AI‑driven customer onboarding and credit‑risk into its Invoice‑to‑Cash suite.
  • Ocean Power Technologies operated three WAM‑V classes at REPMUS 2026 across five mission sets, demonstrating naval interoperability.
  • Evolution Metals was added to the Russell 3000/2000 as it ramps rare‑earth magnet production ahead of DFARS sourcing rules.
  • DFDV grew its SOL treasury about 4% this week, adding roughly 100,000 SOL after an overallotment raised $1.65M.
  • Founder Group received a Nasdaq notice for falling below 500,000 publicly held shares and must submit a compliance plan by Nov 2, 2026.

Latest Articles

HCW Biologics Reaches Milestones for Its Proprietary Tetravalent Second-Generation T-Cell Engager Program On Track To Initiate Clinical Trials in First Half 2027
Jul 23, 2026
Caleb Monroe
Press Releases

HCW Biologics Reaches Milestones for Its Proprietary Tetravalent Second-Generation T-Cell Engager Program On Track To Initiate Clinical Trials in First Half 2027

HCW Biologics announced it has requested a Type B pre-IND meeting with the U.S. FDA to discuss development and regulatory strategies for its lead tetravalent T-cell engager candidate, HCW11-018b. This investigational immunotherapeutic shows promise in treating solid tumors by targeting tissue factor-expressing cancer cells, with demonstrated precli…

HCWB
PetMeds Announces Proposed Sale-Leaseback of Headquarters and Distribution Center Buildings for $37 Million
Jul 23, 2026
Caleb Monroe
Press Releases

PetMeds Announces Proposed Sale-Leaseback of Headquarters and Distribution Center Buildings for $37 Million

PetMed Express, Inc., operating as PetMeds, announced a proposed $37 million sale-leaseback transaction involving its headquarters and distribution center buildings in Delray Beach, Florida. The sale is subject to customary closing conditions and due diligence, with the company planning to lease back the facilities to maintain operations. The trans…

PETS
Portillo’s Appoints Christopher Hansen as Executive Chef and Senior Director of Culinary Innovation
Jul 23, 2026
Avery Klein
Press Releases

Portillo’s Appoints Christopher Hansen as Executive Chef and Senior Director of Culinary Innovation

Portillo's, the Chicago-based fast-casual restaurant chain, has appointed Christopher Hansen as Executive Chef and Senior Director of Culinary Innovation. Hansen brings over 30 years of culinary leadership and will oversee menu strategy to honor the brand's heritage while introducing new offerings, supporting national expansion and enhanced guest e…

PTLO
Inhibikase Therapeutics Announces FDA Orphan Drug Designation Granted to IKT-001 for the Treatment of PAH
Jul 23, 2026
Jordan Park
Press Releases

Inhibikase Therapeutics Announces FDA Orphan Drug Designation Granted to IKT-001 for the Treatment of PAH

Inhibikase Therapeutics announced that the FDA has granted Orphan Drug Designation to its lead product candidate IKT-001, a prodrug of imatinib mesylate, for treating Pulmonary Arterial Hypertension (PAH). This designation recognizes the unmet medical need in PAH, affects around 50,000 US patients, and provides regulatory incentives including poten…

IKT
GPGI Announces Date of Second Quarter 2026 Earnings Call
Jul 23, 2026
Priya Menon
Press Releases

GPGI Announces Date of Second Quarter 2026 Earnings Call

GPGI, Inc., a multi-industry diversified platform listed on NYSE as GPGI, announced that it will host a conference call to discuss its second quarter 2026 financial results on August 6, 2026. The event will include a live webcast and a Q&A session with the leadership team. GPGI operates notable businesses such as CompoSecure and Husky under the man…

GPGI
First Mid Bancshares, Inc. Announces Second Quarter 2026 Results
Jul 23, 2026
Nina Shah
Press Releases

First Mid Bancshares, Inc. Announces Second Quarter 2026 Results

First Mid Bancshares, Inc. announced strong second quarter 2026 financial results, highlighted by record quarterly earnings with net income at $27.8 million and adjusted net income at $33.4 million. The company successfully completed the merger with Two Rivers Bank & Trust, boosting net interest income and wealth management revenues. Despite additi…

FMBH
iMDx GraftAssure Assay Guides Use of Potentially Kidney-Graft-Saving Drug in New Lancet Group Publication
Jul 23, 2026
Maya Rios
Press Releases

iMDx GraftAssure Assay Guides Use of Potentially Kidney-Graft-Saving Drug in New Lancet Group Publication

Insight Molecular Diagnostics (Nasdaq: IMDX) announced the publication of a study in The Lancet Regional Health demonstrating that its GraftAssure assay, which measures donor-derived cell-free DNA (dd-cfDNA), can effectively guide treatment decisions for kidney transplant patients to manage antibody-mediated rejection (AMR). The study builds on pre…

IMDX
Incannex Commences Participant Screening in DReAMzz Phase 2 Study of IHL-42X for Obstructive Sleep Apnea
Jul 23, 2026
Hana Yamamoto
Press Releases

Incannex Commences Participant Screening in DReAMzz Phase 2 Study of IHL-42X for Obstructive Sleep Apnea

Incannex Healthcare announced the commencement of participant screening in its Phase 2 DReAMzz trial evaluating IHL-42X for obstructive sleep apnea (OSA). The drug has FDA Fast Track designation, highlighting its potential to address the unmet need in OSA with no currently approved oral therapies. The DReAMzz study aims to optimize dosing while ass…

IXHL
HomeTrust Bancshares, Inc. Announces Financial Results for the Second Quarter of the Year Ending December 31, 2026 and Declaration of a Quarterly Dividend
Jul 23, 2026
Leila Farooq
Press Releases

HomeTrust Bancshares, Inc. Announces Financial Results for the Second Quarter of the Year Ending December 31, 2026 and Declaration of a Quarterly Dividend

HomeTrust Bancshares, Inc. announced its Q2 2026 financial results, showing net income of $15.6 million down 6.8% from the prior quarter, with diluted EPS declining from $0.99 to $0.94. Despite the slight quarterly earnings decrease, the company increased its quarterly dividend by 15.4% to $0.15 per share and repurchased 153,606 shares. Loan growth…

HTB
Serve Robotics to Report Second Quarter 2026 Financial Results, Host Conference Call and Webcast on August 6
Jul 23, 2026
Sofia Navarro
Press Releases

Serve Robotics to Report Second Quarter 2026 Financial Results, Host Conference Call and Webcast on August 6

Serve Robotics, a Nasdaq-listed autonomous robotics company, will report its second quarter 2026 financial results on August 6, 2026, followed by a conference call and webcast. Since its spin-off from Uber, Serve has deployed over 2,000 robots in the U.S. and expanded operations into indoor service robots with the acquisition of Diligent Robotics.

SERV
Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2026 Financial Results on August 6, 2026
Jul 23, 2026
Leila Farooq
Press Releases

Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2026 Financial Results on August 6, 2026

Apyx Medical Corporation, a NASDAQ-listed company specializing in surgical aesthetics technologies such as Renuvion and the AYON Body Contouring System, announced it will release its second quarter fiscal year 2026 financial results after market close on August 6, 2026. Management will hold a conference call to discuss the results and answer questi…

APYX
Terra Innovatum Initiates NRC Preapplication Readiness Review to Support Solo™ Construction Permit Application
Jul 23, 2026
Avery Klein
Press Releases

Terra Innovatum Initiates NRC Preapplication Readiness Review to Support Solo™ Construction Permit Application

Terra Innovatum Global N.V. has initiated a voluntary preapplication readiness review with the U.S. Nuclear Regulatory Commission (NRC) to support its planned 2026 Construction Permit Application for the SOLO™ Micro-Modular Reactor. This strategic step aims to allow NRC staff early review of safety and environmental draft documentation, enabling id…

NKLR
WillScot to Announce Second Quarter 2026 Results on August 6, 2026 and to Present at an Upcoming Investor Conference in August
Jul 23, 2026
Derek Hwang
Press Releases

WillScot to Announce Second Quarter 2026 Results on August 6, 2026 and to Present at an Upcoming Investor Conference in August

WillScot Holdings Corporation announced it will report its Q2 2026 financial results on August 6, 2026, after market close, followed by a conference call and webcast. The company will also participate in the Deutsche Bank Chicago Industrials Summit on August 11, 2026. WillScot specializes in temporary flexible space solutions serving critical indus…

WSC
UMAC: The Run Has Begun — But This Rally Still Has Room to Run
Jul 23, 2026
Sofia Navarro
Trade Ideas

UMAC: The Run Has Begun — But This Rally Still Has Room to Run

Unusual Machines (UMAC) has ripped higher on government-program chatter and index inclusion, pushing the stock back toward its 52-week high. Fundamentals remain early-stage and loss-making, but meaningful cash on the balance sheet, short-coverable float and active defense catalysts create a tradeable asymmetric setup. This piece lays out an actiona…

UMAC
Syntec Optics (Nasdaq: OPTX) Included in Russell 3000® Index
Jul 23, 2026
Hana Yamamoto
Press Releases

Syntec Optics (Nasdaq: OPTX) Included in Russell 3000® Index

Syntec Optics Holdings, Inc., a leading manufacturer of high-precision optics and photonics technologies serving defense and space sectors, announced its inclusion in the Russell 3000® Index. This inclusion enhances the company's visibility to a broad range of investors and mutual funds tracking this key U.S. equity benchmark, potentially increasin…

OPTX